Spanish Clinical Research Network
National, non-profit platform funded by the Instituto de Salud Carlos III and co-funded by EU structural funds that provides scientific-technical support for independent/academic clinical research. Operates as a network of clinical research units across Spain coordinated from a major university hospital. Provides operational support for multicentre and international clinical projects, including trial management, monitoring, pharmacovigilance, data management and statistical analysis.
Industries
Nr. of Employees
large (251-1000)
Spanish Clinical Research Network
Services
Project management, monitoring, pharmacovigilance, data management and statistical support for interventional and observational studies.
Management of participant clinical research units across autonomous communities, site selection and initiation.
Guidance and operational support for regulatory authorisations and ethical approvals required in Spain.
Project management, monitoring, pharmacovigilance, data management and statistical support for interventional and observational studies.
Management of participant clinical research units across autonomous communities, site selection and initiation.
Guidance and operational support for regulatory authorisations and ethical approvals required in Spain.
Expertise Areas
- Clinical trial management
- Multicentre trial coordination
- Pharmacovigilance
- Clinical data management and biostatistics
Key Technologies
- Clinical trial management systems (CTMS)
- Electronic data capture (EDC) systems
- Pharmacovigilance reporting systems
- Biostatistical analysis and statistical planning
News & Updates
Publication marking the platform's 10-year anniversary and activities.
Protocol publication for a multicenter randomized clinical trial on clozapine in adults with intellectual disability and treatment-resistant psychosis.
Publication marking the platform's 10-year anniversary and activities.
Protocol publication for a multicenter randomized clinical trial on clozapine in adults with intellectual disability and treatment-resistant psychosis.